226 related articles for article (PubMed ID: 23370280)
1. Tumor suppressor WWOX binds to ΔNp63α and sensitizes cancer cells to chemotherapy.
Salah Z; Bar-mag T; Kohn Y; Pichiorri F; Palumbo T; Melino G; Aqeilan RI
Cell Death Dis; 2013 Jan; 4(1):e480. PubMed ID: 23370280
[TBL] [Abstract][Full Text] [Related]
2. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.
Abu-Odeh M; Bar-Mag T; Huang H; Kim T; Salah Z; Abdeen SK; Sudol M; Reichmann D; Sidhu S; Kim PM; Aqeilan RI
J Biol Chem; 2014 Mar; 289(13):8865-80. PubMed ID: 24550385
[TBL] [Abstract][Full Text] [Related]
3. WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response.
Abu-Odeh M; Salah Z; Herbel C; Hofmann TG; Aqeilan RI
Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4716-25. PubMed ID: 25331887
[TBL] [Abstract][Full Text] [Related]
4. U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha.
Chatterjee A; Upadhyay S; Chang X; Nagpal JK; Trink B; Sidransky D
Cell Cycle; 2008 May; 7(9):1231-7. PubMed ID: 18418053
[TBL] [Abstract][Full Text] [Related]
5. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
Li Y; Zhou Z; Chen C
Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
[TBL] [Abstract][Full Text] [Related]
6. Molecular origin of the binding of WWOX tumor suppressor to ErbB4 receptor tyrosine kinase.
Schuchardt BJ; Bhat V; Mikles DC; McDonald CB; Sudol M; Farooq A
Biochemistry; 2013 Dec; 52(51):9223-36. PubMed ID: 24308844
[TBL] [Abstract][Full Text] [Related]
7. Biophysical basis of the binding of WWOX tumor suppressor to WBP1 and WBP2 adaptors.
McDonald CB; Buffa L; Bar-Mag T; Salah Z; Bhat V; Mikles DC; Deegan BJ; Seldeen KL; Malhotra A; Sudol M; Aqeilan RI; Nawaz Z; Farooq A
J Mol Biol; 2012 Sep; 422(1):58-74. PubMed ID: 22634283
[TBL] [Abstract][Full Text] [Related]
8. The Tumor-Suppressor WWOX and HDAC3 Inhibit the Transcriptional Activity of the β-Catenin Coactivator BCL9-2 in Breast Cancer Cells.
El-Hage P; Petitalot A; Monsoro-Burq AH; Maczkowiak F; Driouch K; Formstecher E; Camonis J; Sabbah M; Bièche I; Lidereau R; Lallemand F
Mol Cancer Res; 2015 May; 13(5):902-12. PubMed ID: 25678599
[TBL] [Abstract][Full Text] [Related]
9. Wwox-Brca1 interaction: role in DNA repair pathway choice.
Schrock MS; Batar B; Lee J; Druck T; Ferguson B; Cho JH; Akakpo K; Hagrass H; Heerema NA; Xia F; Parvin JD; Aldaz CM; Huebner K
Oncogene; 2017 Apr; 36(16):2215-2227. PubMed ID: 27869163
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1α stabilization/nuclear translocation in bone metastasis from breast carcinoma.
Maroni P; Matteucci E; Drago L; Banfi G; Bendinelli P; Desiderio MA
Exp Cell Res; 2015 Jan; 330(2):287-299. PubMed ID: 25447306
[TBL] [Abstract][Full Text] [Related]
11. Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors.
Li J; Liu J; Ren Y; Yang J; Liu P
Int J Biol Sci; 2014; 10(2):142-8. PubMed ID: 24520212
[TBL] [Abstract][Full Text] [Related]
12. Allostery mediates ligand binding to WWOX tumor suppressor via a conformational switch.
Schuchardt BJ; Mikles DC; Bhat V; McDonald CB; Sudol M; Farooq A
J Mol Recognit; 2015 Apr; 28(4):220-31. PubMed ID: 25703206
[TBL] [Abstract][Full Text] [Related]
13. Wwox suppresses breast cancer cell growth through modulation of the hedgehog-GLI1 signaling pathway.
Xiong A; Wei L; Ying M; Wu H; Hua J; Wang Y
Biochem Biophys Res Commun; 2014 Jan; 443(4):1200-5. PubMed ID: 24393846
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.
Chan W; Tian R; Lee YF; Sit ST; Lim L; Manser E
J Biol Chem; 2009 Mar; 284(12):8185-94. PubMed ID: 19144635
[TBL] [Abstract][Full Text] [Related]
15. Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance.
Huang Y; Bell LN; Okamura J; Kim MS; Mohney RP; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Oct; 11(20):3810-27. PubMed ID: 22951905
[TBL] [Abstract][Full Text] [Related]
16. WWOX: its genomics, partners, and functions.
Del Mare S; Salah Z; Aqeilan RI
J Cell Biochem; 2009 Nov; 108(4):737-45. PubMed ID: 19708029
[TBL] [Abstract][Full Text] [Related]
17. MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation.
Galli F; Rossi M; D'Alessandra Y; De Simone M; Lopardo T; Haupt Y; Alsheich-Bartok O; Anzi S; Shaulian E; Calabrò V; La Mantia G; Guerrini L
J Cell Sci; 2010 Jul; 123(Pt 14):2423-33. PubMed ID: 20571051
[TBL] [Abstract][Full Text] [Related]
18. DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance.
Danilov AV; Neupane D; Nagaraja AS; Feofanova EV; Humphries LA; DiRenzo J; Korc M
PLoS One; 2011; 6(10):e26815. PubMed ID: 22053213
[TBL] [Abstract][Full Text] [Related]
19. WW domain-containing oxidoreductase: a candidate tumor suppressor.
Chang NS; Hsu LJ; Lin YS; Lai FJ; Sheu HM
Trends Mol Med; 2007 Jan; 13(1):12-22. PubMed ID: 17142102
[TBL] [Abstract][Full Text] [Related]
20. Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
Jeon YJ; Jo MG; Yoo HM; Hong SH; Park JM; Ka SH; Oh KH; Seol JH; Jung YK; Chung CH
J Clin Invest; 2012 Jul; 122(7):2622-36. PubMed ID: 22706304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]